1. Roles of 14-3-3η in mitotic progression and its potential use as a therapeutic target for cancers.
- Author
-
Lee CG, Park GY, Han YK, Lee JH, Chun SH, Park HY, Lim KH, Kim EG, Choi YJ, Yang K, and Lee CW
- Subjects
- 14-3-3 Proteins antagonists & inhibitors, Aneuploidy, Apoptosis drug effects, Caspase 9 physiology, Cell Division, Forkhead Box Protein O3, Forkhead Transcription Factors physiology, G2 Phase, HeLa Cells, Humans, Microtubules drug effects, Neoplasms pathology, Nocodazole pharmacology, 14-3-3 Proteins physiology, Mitosis, Neoplasms drug therapy
- Abstract
14-3-3 proteins are involved in several cellular processes, including the G1/S and G2/M cell cycle transitions. However, their roles during mitosis are not well understood. Here, we showed that depletion of 14-3-3η, a 14-3-3 protein isoform, enhanced mitotic cell death, resulting in sensitization to microtubule inhibitors and inhibition of aneuploidy formation. The enhanced mitotic cell death by depletion of 14-3-3η appeared to be both caspase-dependent and independent. Furthermore, enhanced mitotic cell death and a reduction in aneuploidy following 14-3-3η depletion were independent of the mitotic checkpoint, which is thought to be the primary signaling event in the regulation of the cell death induced by microtubule inhibitors. When 14-3-3η depletion was combined with microtubule inhibitors in HCT116 and U87MG cells, it sensitized both cancer cell lines to microtubule inhibitors. These results collectively suggest that 14-3-3η may be required for mitotic progression and may be considered as a novel anti-cancer strategy in combination with microtubule inhibitors.
- Published
- 2013
- Full Text
- View/download PDF